Aura Biosciences, Inc. (AURA)
7.185
-0.18
(-2.38%)
USD |
NASDAQ |
Sep 09, 16:00
7.185
0.00 (0.00%)
After-Hours: 16:50
Aura Biosciences Shareholders Equity (Quarterly) : 315.27M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 315.27M |
| March 31, 2026 | 107.25M |
| December 31, 2025 | 136.91M |
| September 30, 2025 | 156.67M |
| June 30, 2025 | 174.63M |
| March 31, 2025 | 127.97M |
| December 31, 2024 | 151.97M |
| September 30, 2024 | 174.67M |
| June 30, 2024 | 191.45M |
| March 31, 2024 | 208.78M |
| December 31, 2023 | 225.85M |
| September 30, 2023 | 151.72M |
| Date | Value |
|---|---|
| June 30, 2023 | 166.44M |
| March 31, 2023 | 180.26M |
| December 31, 2022 | 195.58M |
| September 30, 2022 | 115.05M |
| June 30, 2022 | 129.09M |
| March 31, 2022 | 141.09M |
| December 31, 2021 | 152.32M |
| September 30, 2021 | 84.29M |
| June 30, 2021 | 92.55M |
| March 31, 2021 | 101.12M |
| December 31, 2020 | 19.36M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
| Sangamo Therapeutics, Inc. | -18.96M |
| Sarepta Therapeutics, Inc. | 1.528B |
| Anixa Biosciences, Inc. | 14.48M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 348.13M |
| Total Liabilities (Quarterly) | 32.86M |
| Debt to Equity Ratio | 0.0526 |
| Current Ratio | 16.82 |
| Net Debt Paydown Yield | 0.05% |